Study guide

3.3 Independent Pharmacist Furnishing Scope

California Practice Standards and Jurisprudence Examination for Pharmacists CPJE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Patient Information & Prescription Evaluation (Domain 1)

1.1 Patient Profile & Health Data Acquisition 1.2 Prescription Authenticity & Prescriber Authority 1.3 California Security Prescription Forms & E-Prescribing Mandates (B&P § 688) 1.4 Clinical Evaluation of Dosing & Organ Impairment 1.5 Drug-Drug & CYP450 Interactions 1.6 Special Populations & High-Risk Medications 1.7 Physical Assessment & Health Screening 1.8 Final Check, Labeling Verification & Product Selection Workflow

2 Chapter 2: Clinical Practice & Disease State Management (Domain 2: Clinical Practice & Jurisprudence)

2.1 Cardiovascular Therapeutics & Clinical Law 2.2 Endocrine & Metabolic Disorders 2.3 Respiratory & Infectious Disease Management 2.4 Central Nervous System & Pain Management 2.5 Oncology, Immunology & Specialty Pharmacy 2.6 Medication Therapy Management & Collaborative Goals of Therapy 2.7 Formulary Systems, Therapeutic Interchange & Medication Affordability 2.8 Medication Reconciliation & Ordering Monitoring Procedures

3 Chapter 3: California Pharmacy Jurisprudence & Prescriptive Authority (Domain 2: Clinical Practice & Jurisprudence)

3.1 Controlled Substances & CURES PDMP 3.2 Controlled Substance Dispensing, Refills, & Partial Fills 3.3 Independent Pharmacist Furnishing Scope 3.4 Advanced Pharmacist Practitioner (APP/APh) & CDTM 3.5 Immunization Authority & CAIR Reporting 3.6 Patient Counseling & Patient-Centered Labeling 2.9 OTC, CAM, Lifestyle Counseling & Teach-Back 2.10 Educating Health Professionals & Supplemental Patient Information

4 Chapter 4: Pharmacy Operations, Board Governance & Personnel (Domain 3: Pharmacy Operations & Jurisprudence)

California Board of Pharmacy Governance & Licensure Pharmacist Continuing Education & License Maintenance Pharmacist-in-Charge (PIC) & Pharmacy Ownership Pharmacy Personnel & Supervision Ratios Pharmacy Security, Theft, & Diversion Reporting 4.6 Controlled Substance Inventory & Record Reconciliation 4.7 Quality Assurance, Medication Error Systems & ADR Reporting 4.8 Privacy, Confidentiality & Pharmacy Policies and Procedures

5 Chapter 5: Drug Supply Chain, Dispensing & Compounding Regulations (Domain 3: Pharmacy Operations & Jurisprudence)

5.1 Drug Procurement, DSCSA Track & Trace, & Storage 5.2 Generic Substitution, Bioequivalence, & Orange Book 5.3 Prescription Transfer, Refills, & Off-Site Dispensing 5.4 Non-Sterile Compounding Standards 5.5 Sterile Compounding & Hazardous Drug Handling 5.6 Emergency Preparedness & Continuity of Pharmacy Operations

3.3 Independent Pharmacist Furnishing Scope

Key Takeaways Explain This Topic AI

Pharmacists can furnish self-administered hormonal contraception (16 CCR § 1746.1).

Naloxone can be furnished to individuals at risk or those who may assist them (16 CCR § 1746.3).

Nicotine Replacement Therapy (NRT) products, including prescription-only options, can be furnished (16 CCR § 1746.2).

Pharmacists can furnish HIV PrEP (up to 60 days) and PEP (full course) under 16 CCR § 1747.

Last updated: July 2026

Pharmacist Independent Furnishing Authority

Under Business and Professions Code (B&P) § 4052, California pharmacists have been granted extensive independent furnishing authority to improve public health access. "Furnishing" means supplying a prescription drug to a patient without a direct prescription from a physician, acting instead under a statewide protocol or statutory authority. This represents a major shift toward pharmacists acting as independent healthcare providers in specific clinical areas.

1. Self-Administered Hormonal Contraception (16 CCR § 1746.1)

Pharmacists are authorized to furnish self-administered hormonal contraceptives, which include oral contraceptive pills, transdermal patches, vaginal rings, and depot medroxyprogesterone acetate (DMPA) injections. The protocol requires the pharmacist to follow a specific step-by-step procedure:

Patient Screening: The pharmacist must have the patient complete a self-screening tool (often the US MEC-based questionnaire) to identify any contraindications, such as a history of deep vein thrombosis, breast cancer, or uncontrolled hypertension.

Blood Pressure Check: If the requested contraceptive contains estrogen, the pharmacist must measure and record the patient's seated blood pressure.

Counseling: The pharmacist must provide counseling on the proper use of the contraceptive, potential side effects, the importance of STI protection (as contraceptives do not protect against STIs), and what to do if doses are missed.

Fact Sheet: The pharmacist must provide a birth control guide or fact sheet, such as the CDC or FDA-approved information.

Record Keeping and Notification: The pharmacist must document the encounter, maintain records for at least three years, and notify the patient's primary care provider (if the patient has one and consents to notification).

2. Naloxone for Opioid Overdose (16 CCR § 1746.3)

To combat the opioid epidemic, pharmacists can furnish naloxone hydrochloride to individuals at risk of an opioid-related overdose or to family members, friends, or other persons in a position to assist an at-risk individual.

Screening: The pharmacist screens the individual to determine if they understand the signs of an overdose.

Training and Counseling: The pharmacist must provide counseling on overdose prevention, recognition, and response (including calling 911), and demonstrate how to administer the naloxone (intranasal, intramuscular, or auto-injector).

Fact Sheet: The pharmacist provides the recipient with a fact sheet approved by the Board.

Record Keeping: The pharmacy must keep records of the furnishing for at least three years. Interestingly, the recipient's identity is strictly confidential, and if they are acquiring it for someone else, the pharmacist does not need to identify the ultimate user.

3. Nicotine Replacement Therapy (16 CCR § 1746.2)

Pharmacists can furnish prescription Nicotine Replacement Therapy (NRT), such as nicotine inhalers and nicotine nasal sprays, as well as over-the-counter NRTs.

Training Requirement: The pharmacist must complete an approved training program in smoking cessation.

Screening: The pharmacist screens the patient for pregnancy (if pregnant, refer to a provider), recent heart attacks, irregular heartbeats, or severe angina. If these high-risk conditions are present, furnishing must be coordinated with the patient's primary care provider.

Counseling: The pharmacist counsels on behavioral modification strategies and the proper use of the NRT.

Notification: The patient's primary care provider must be notified.

4. HIV Pre-Exposure (PrEP) and Post-Exposure (PEP) Prophylaxis (16 CCR § 1747)

Pharmacists play a critical role in HIV prevention by furnishing PrEP and PEP.

PrEP (Pre-Exposure Prophylaxis): Pharmacists can furnish up to a 60-day supply of PrEP (e.g., tenofovir disoproxil fumarate/emtricitabine). The pharmacist must ensure the patient has a negative HIV test result within the last 7 days. If the patient does not have a test result, the pharmacist can order an HIV test. The pharmacist provides counseling on adherence and safe sex practices. Pharmacists cannot furnish more than a 60-day supply to a single patient more frequently than once every two years without a prescription.

PEP (Post-Exposure Prophylaxis): Pharmacists can furnish a complete 28-day course of PEP for individuals who may have been exposed to HIV within the last 72 hours. The pharmacist must screen the patient for exposure risk, offer HIV testing (though furnishing PEP is not strictly contingent on an immediate test result if it delays care), and provide extensive counseling on the 28-day regimen.

For both PrEP and PEP, the pharmacist must notify the patient's primary care provider (with consent) and keep detailed records. Pharmacists must undergo specialized training approved by the Board before furnishing PrEP/PEP.

Summary Table of Furnishing Requirements

  • Furnishing Category Key Screening/Requirement Counseling/Action
  • Hormonal Contraceptives US MEC Questionnaire, BP (if estrogen) Counsel on use, side effects, STI warning
  • Naloxone Overdose recognition ability Counsel on administration, call 911, fact sheet

Nicotine Replacement Screen for recent MI, arrhythmias, pregnancy Counsel on behavioral modification, proper use

  • HIV PrEP Negative HIV test within 7 days Furnish up to 60-day supply, order labs if needed
  • HIV PEP Exposure within last 72 hours Furnish full 28-day course, prompt initiation